Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla (ONCE)

This study has been completed.
Information provided by (Responsible Party):
Gilead Sciences Identifier:
First received: February 4, 2008
Last updated: November 18, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)